Top Section/Ad
Top Section/Ad
Most recent
Sfr4.9bn trade is largest European ECM deal since National Grid’s £7bn rights issue in 2024
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
More articles/Ad
More articles/Ad
More articles
-
The final Latin American corporate deal before a hiatus for the earnings blackout period showed that borrowers were benefiting from volatility related to Covid-19, the official name of the coronavirus outbreak. However, a prolonged scare could bring negative consequences. -
Asian IPOs are suffering as the spread of Covid-19 (the coronavirus) accelerates, with the flow of Chinese listings in Hong Kong having slowed to a standstill. Bankers are looking into any solutions, but the curb of face-to-face contact is hanging over the world’s busiest stock exchange. Jonathan Breen reports.
-
Agricultural Development Bank of China has sold Rmb14.5bn ($2.1bn) of bonds to combat the Covid-19 (coronavirus) outbreak, including a deal in the dim sum bond market this week. Rebecca Feng reports.
-
Investors in the SSA market are piling into long dated bonds, leaving aside any coronavirus-driven fears and swelling the order books on 30 year and 50 year paper to record breaking levels, in what bankers are calling a 'one way market'.
-
Canada’s DRI Capital is preparing to list a new fund on the London Stock Exchange focused on investing in pharmaceuticals royalties.
-
The value of the riskier tranche of the World Bank’s pandemic bond has been discounted — but not by very much — as the coronavirus outbreak infects more people outside of China and therefore comes closer to triggering a payout from the notes.
